Resmetirom for Steatotic Liver Disease: Does Data Support Widespread Use?
{{output}}
Metabolic dysfunction-associated steatohepatitis with significant fibrosis is the aggressive form of steatotic liver disease that can progress to cirrhosis and its complications. Resmetirom is a liver-directed thyroid hormone receptor beta agonist that recentl... ...